NASDAQ:MGCD (MGCD) (MGCD) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free MGCD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$11.03▼$11.0350-Day Range N/A52-Week Range$6.24▼$11.20VolumeN/AAverage Volume15,965 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (MGCD) alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About (MGCD)MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.Read More Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. MGCD Stock News HeadlinesJanuary 9, 2024 | msn.comSonu Sood’s ‘Fateh’ is a cinematic tribute to cybercrime victimsDecember 31, 2023 | msn.comLakers' LeBron James irate after foot on line discounts potential tying shot in loss to TimberwolvesMarch 28, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.November 6, 2023 | msn.com‘Defuse it quickly;’ Police arrest Springfield student who brought gun to football gameApril 5, 2023 | reuters.comSpencer Torkelson knocks in three as Tigers beat AstrosFebruary 11, 2023 | msn.comBusy Wednesday schedule kept Jenna Ortega from returning to You Season 4December 29, 2022 | msn.comWrexham science discovery centre to launch Monday warm hub drop in sessionsDecember 17, 2022 | msn.comF1 News: 2023 Aston Martin AMR23 Reveal Date AnnouncedMarch 28, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionOctober 25, 2022 | msn.comThe Northern Belle train returns to Grantham for rare appearance this ChristmasSeptember 28, 2022 | msn.comOpen Thread: Buffalo Sabres vs. Columbus Blue Jackets (Preseason)August 18, 2022 | msn.comL.A. County authorities search for woman, 23, missing since JulySee More Headlines Receive MGCD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (MGCD) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/07/2016Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:MGCD Previous SymbolNASDAQ:ANGN CUSIPN/A CIK815093 Webmgcdiagnostics.com Phone+1-651-4844874FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesGreg GreenbergChairman of the BoardMatthew S. Margolies (Age 50)President Todd M. Austin (Age 54)Chief Executive Officer Larry Robert Degen (Age 62)Interim Chief Financial Officer, Chief Accounting Officer, Secretary Hendrik Struik (Age 49)Independent Director MGCD Stock Analysis - Frequently Asked Questions How were (MGCD)'s earnings last quarter? (MGCD) (NASDAQ:MGCD) posted its quarterly earnings results on Wednesday, September, 7th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter. The medical equipment provider had revenue of $9.90 million for the quarter, compared to the consensus estimate of $9.20 million. What other stocks do shareholders of (MGCD) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (MGCD) investors own include Allena Pharmaceuticals (ALNA), Akers Biosciences (AKER), Ampliphi Biosciences (APHB), Veru (VERU), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), Achieve Life Sciences (ACHV), AcelRx Pharmaceuticals (ACRX), Acacia Research (ACTG) and Achaogen (AKAO). This page (NASDAQ:MGCD) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (MGCD) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.